Combined Nutrient Intake and Muscle Protein Synthesis
1 other identifier
interventional
48
1 country
1
Brief Summary
Dietary intervention to prevent sarcopenia in elderly people. The objective of this study is to test whether combined nutrient intake plays an important role in stimulation of the muscle protein growth in elderly people; and whether it represent effective strategies to overcome the impaired muscle protein synthesis in elderly when compared with young subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2011
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2010
CompletedFirst Posted
Study publicly available on registry
November 11, 2010
CompletedStudy Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedSeptember 14, 2011
September 1, 2011
6 months
November 10, 2010
September 13, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle protein synthesis
Muscle protein synthesis will be expressed as fractional synthetic rate (FSR) by dividing the increment in enrichment in the product, i.e. protein-bound C13phe, by the enrichment of the precursor (=plasma availability).
6 h postprandial period
Study Arms (4)
protein (elderly)
EXPERIMENTALprotein and carbohydrate (elderly)
EXPERIMENTALprotein and carbohydrate (young)
EXPERIMENTALprotein and leucine (elderly)
EXPERIMENTALInterventions
20g protein and 20g carbohydrate
Eligibility Criteria
You may qualify if:
- males
- years or 18-30 years
- BMI \< 30
You may not qualify if:
- Type II diabetes
- All co morbidities interacting with mobility and muscle metabolism of the lower limbs
- Use of anticoagulants
- Patients suffering from Phenylketonuria
- Participation in any regular exercise programme
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universiteit Maastricht, Bewegingswetenschappen
Maastricht, Limburg, Netherlands
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
A. de Lange
Maastricht University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 10, 2010
First Posted
November 11, 2010
Study Start
January 1, 2011
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
September 14, 2011
Record last verified: 2011-09